Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The P values are from the Seurat Wilcoxon rank-sum test, and the adjusted P values are BenjaminiHochberg false discovery rate FDR-corrected P values
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)
Niacin can also cause bloating, burping, facial redness, and increased gas
Front Endocrinol (Lausanne) 2022;13:863592.PubMedPMC 43
US$ 27.93
US$ 21.07
US$ 25.02
US$ 29.20
US$ 27.85
US$ 28.61
